Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
285 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
3009 (91%)
3305
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
411 (94%)
Reversed:
23 (5%)
436
485 (13%)
23 (8%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2020-03-12 | 2020-08-27 | 108601 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2020-11-06 | 2021-01-07 | 128028 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2024-12-10 | 2025-04-24 | 245304 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2019-08-22 | 2019-10-10 | 92198 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-07 | 2020-01-27 | 98185 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-28 | 2020-06-25 | 99955 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144454 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2025-07-03 | 2026-03-12 | 261785 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2020-04-23 | 2020-08-27 | 113031 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2021-08-24 | 2022-01-07 | 144494 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144448 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144451 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2021-08-24 | 2022-01-07 | 144497 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2025-01-30 | 2025-04-24 | 249198 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2020-02-21 | 2020-04-09 | 106925 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2025-08-14 | 2026-03-12 | 265143 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-07 | 2020-02-21 | 98179 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2024-12-20 | 2026-03-12 | 246267 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2020-08-06 | 2020-11-07 | 121865 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Resolved | 2017-08-01 | 2018-05-08 | 17779 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258490 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |